ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ACAD announcements Acadia Pharmaceuticals Inc. announcements and dividends declared NASDAQ

Acadia Pharmaceuticals Inc. Complete list of announcements declared & dividend announcements by Acadia Pharmaceuticals Inc. ACAD

Acadia Pharmaceuticals Inc. ACAD listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Acadia Pharmaceuticals Inc. ACAD

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates (Revised)
Acadia (ACAD) delivered earnings and revenue surprises of 10% and 1.23%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 09 May 2025

Acadia Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Acadia Pharmaceuticals Inc (Symbol: ACAD) have crossed above the average analyst 12-month target price of .06, changing hands for .34/share. When a stock reaches the target an analyst has set, the analyst logically has t
Announcement as on 22 August 2023

Cantor Fitzgerald Maintains Acadia Pharmaceuticals (ACAD) Overweight Recommendation
Fintel reports that on July 17, 2023, Cantor Fitzgerald maintained coverage of Acadia Pharmaceuticals (NASDAQ:ACAD) with a Overweight recommendation. Analyst Price Forecast Suggests 24.48% Downside
Announcement as on 18 July 2023

: Acadia Pharmaceuticals stock rockets 30% following expanded drug rights
Acadia Pharmaceuticals Inc. ACAD shares rallied in the extended session Thursday after the drug maker said it expanded its rights to a treatment for a rare neurological disorder. Acadia shares rallied as much as 30% after hours, following a 0.2% decline to
Announcement as on 13 July 2023

Acadia Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Acadia Pharmaceuticals Inc (Symbol: ACAD) have crossed above the average analyst 12-month target price of .47, changing hands for .48/share. When a stock reaches the target an analyst has set, the analyst logically has t
Announcement as on 20 January 2023

Announcements by Acadia Pharmaceuticals Inc. first page | Next page |

ACAD Acadia Pharmaceuticals Inc. current price & indicator signals

Moving Averages for Acadia Pharmaceuticals Inc.

  • 5Day Average: 26.03
  • 12Day Average: 24.82
  • 20Day Average: 24.3
  • 50Day Average: 22.64
  • 100Day Average: 23.48
  • 150Day Average: 22.58
  • 200Day Average: 21.04

ACAD Indicators & signals

Indicator MACD (12,26,9)

25.22, 24.23, 0.69
Indicator MACD is in positive zone

Indicator ADX (14)

65, 35.48, 7.53
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ACAD Acadia Pharmaceuticals Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 27.43 26.74 to 27.61 3.31% 1.02 times
04 Thu Dec 2025 26.55 25.40 to 26.76 2.59% 1.3 times
03 Wed Dec 2025 25.88 25.29 to 26.12 1.77% 1.03 times
02 Tue Dec 2025 25.43 24.87 to 25.67 2.33% 1.24 times
01 Mon Dec 2025 24.85 24.58 to 25.21 -0.76% 0.77 times
28 Fri Nov 2025 25.04 24.56 to 25.12 0.93% 0.4 times
26 Wed Nov 2025 24.81 24.20 to 25.20 1.72% 1.34 times
25 Tue Nov 2025 24.39 24.00 to 24.66 2.05% 0.82 times
24 Mon Nov 2025 23.90 23.10 to 23.92 1.44% 1.31 times
21 Fri Nov 2025 23.56 22.84 to 23.98 2.88% 0.97 times
20 Thu Nov 2025 22.90 22.81 to 23.61 -0.87% 0.82 times
19 Wed Nov 2025 23.10 22.85 to 23.73 -2.94% 1.04 times

Videos related to: ACAD announcements Acadia Pharmaceuticals Inc. announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

ACAD announcements Acadia Pharmaceuticals Inc. announcements and dividends declared NASDAQ

 

Back to top